Tscan Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.98

+0.00 (+0.27%)

As of Jun 30, 10:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +1,062.1% upside

Low Target $7.11

Average Target $11.39

High Target $14.81

Current Price $0.98

Current
$0.98

Target
$11.39

$7.11 $11.39 avg $14.81

Scenario Analysis

Bear Case

$7.11

625.4%

Low target

Base Case

$11.39

+1,062.1%

Avg target

Bull Case

$14.81

+1,411.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.57

-61.9% from high

52-Week Low

$0.83

+18.8% from low

Target vs 52W High

$11.39

+343.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%